OverviewSuggest Edit
Calcivis is a dental biologic and device manufacturer. It focuses on the treatment of tooth decay and enabling preventive dentistry. The company provides an imaging system that allows dental practitioners to offer evidence-based preventive treatment for dental caries patients.
| Type | Private | |
| Founded | 2012 | |
| HQ | Edinburgh, GB | Map |
| Website | calcivis.com |
Key People/Management at Calcivis
James Browning
Chairman
Adam Christie
CEO
Bruce Vernon
CTO
Calcivis Office Locations
Calcivis has offices in Edinburgh and Boston
Edinburgh, GB (HQ)
9 Little France Rd
Boston, MA, US
One Marina Park Drive Suite 1410
Calcivis Financials and Metrics
Summary Metrics
Founding Date | 2012 |
Calcivis total Funding | $22.3 m |
Calcivis latest funding size | $5.48 m |
Time since last funding | 2 years ago |
Calcivis investors | Scottish Investment Bank, ArchAngels, Biomedical Catalyst Fund, Archangel Investors, EASME - EU Executive Agency for SMEs, Julz, Hedge Fund |
Calcivis's latest funding round in September 2019 was reported to be $5.5 m. In total, Calcivis has raised $22.3 m
Calcivis Revenue
Calcivis's revenue was reported to be £12.16 k in FY, 2018
| GBP | |
|---|---|
Revenue (FY, 2018) | 12.2k |
Gross profit (FY, 2018) | 8.1k |
Gross profit margin (FY, 2018), % | 66.9% |
Net income (FY, 2018) | (2.7m) |
EBIT (FY, 2018) | (3.0m) |
Cash (31-Oct-2018) | 1.9m |
| GBP | FY, 2015 | FY, 2016 | FY, 2018 |
|---|---|---|---|
Revenue | 465.3k | 1.1m | 12.2k |
Cost of goods sold | 4.0k | ||
Gross profit | 8.1k | ||
Gross profit Margin, % | 67% |
| GBP | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|---|---|
Cash | 421.9k | 1.5m | 792.3k | 1.8m | 1.9m |
Accounts Receivable | 162.5k | ||||
Inventories | 3.4k | 159.7k | |||
Current Assets | 584.3k | 1.6m | 2.3m | 2.0m | 2.6m |
| GBP | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|---|
Cash From Operating Activities | (55.5k) | (2.0m) | (1.2m) | (2.8m) |
Cash From Investing Activities | (33.8k) | (13.3k) | (8.9k) | (10.3k) |
Cash From Financing Activities | 1.2m | 1.2m | 2.2m | 3.0m |
Net Change in Cash | 1.1m | (752.5k) | 1.0m | 120.9k |
| GBP | FY, 2014 |
|---|---|
Financial Leverage | 1.2 x |
Calcivis Cybersecurity Score
Calcivis Online and Social Media Presence
655 Twitter followers
Calcivis has 655 Twitter Followers. The number of followers has decreased 0.2% month over month and decreased 0.6% quarter over quarter
Calcivis's Trends
Calcivis Blogs
March 29, 2021
Publication of Calcivis Imaging System pivotal clinical study
Calcivis announces the publication of two key clinical and scientific papers in the journal, Clinical and Experimental Dental Research. Both are available via Open Access on the Wiley Online Library, using the links below. The pivotal clinical study was designed in consultation with the FDA, to supp…
March 05, 2020
CALCiViS receives Approvable Letter for its unique CALCiViS® Imaging System from US FDA
CALCiViS System, developed to enable and drive the adoption of preventive dentistry – enables real-time visualisation of active tooth decay Edinburgh, March 5th 2020 – CALCiViS, a medical devices company focused on modernising the management of tooth decay and enabling preventive dentistry, announ…
November 28, 2019
An update on caries prevention
Fluoride varnish applications are usually targeted at children with a high risk of caries, or where it is considered beneficial to complement the fluoride found in water, from dietary sources and toothpaste. The preventive effect of fluoride varnish has been the subject of numerous studies conducted…
November 25, 2019
Focus on caries prevention
There is overwhelming evidence and agreement that fluoride is safe and highly effective for the prevention of tooth decay.[i] There are a range of fluoride modalities in the modern day that help to reduce the prevalence and severity of dental caries. These include individual use at home, through flu…
November 23, 2019
The effective management of erosive tooth wear
Dental erosion is a widespread condition with prevalence rates that appear to have increased in recent decades, particularly in young adults.[1] Currently, it is the third most commonly observed oral condition after caries and periodontal disease and is drawing increased attention as a risk factor f…
November 12, 2019
Profit from private
There are a multitude of advantages to working in the NHS including security, pension and employment benefits. Private dentistry has however, has experienced healthy growth in recent years, helped in part by the growing interest in cosmetic dentistry, specialist treatments and hygiene services. It i…
Calcivis Frequently Asked Questions
When was Calcivis founded?
Calcivis was founded in 2012.
Who are Calcivis key executives?
Calcivis's key executives are James Browning, Adam Christie and Bruce Vernon.
How many employees does Calcivis have?
Calcivis has 8 employees.
What is Calcivis revenue?
Latest Calcivis annual revenue is £12.2 k.
What is Calcivis revenue per employee?
Latest Calcivis revenue per employee is £1.5 k.
Who are Calcivis competitors?
Competitors of Calcivis include BoneProx, GLO Science and Convergent Dental.
Where is Calcivis headquarters?
Calcivis headquarters is located at 9 Little France Rd, Edinburgh.
Where are Calcivis offices?
Calcivis has offices in Edinburgh and Boston.
How many offices does Calcivis have?
Calcivis has 2 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies